Posted by Michael Wonder on 20 Dec 2025
Two new treatments recommended for people with breast cancer
19 December 2025 - Breast Cancer Network Australia welcomes the PBAC's recommendation to subsidise two important medicines on the PBS: Veoza (fezolinetant) for severe menopause symptoms and Tukysa (tucatinib) for HER2 positive metastatic breast cancer.
This is the first non-hormonal treatment developed to target moderate to severe vasomotor symptoms such as hot flushes and night sweats.
